These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26806825)

  • 21. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J
    JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010.
    Gu Q; Burt VL; Dillon CF; Yoon S
    Circulation; 2012 Oct; 126(17):2105-14. PubMed ID: 23091084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC; Ayala DE; Fernández JR; Mojón A
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial fibrillation and isolated systolic hypertension: the systolic hypertension in the elderly program and systolic hypertension in the elderly program-extension study.
    Vagaonescu TD; Wilson AC; Kostis JB
    Hypertension; 2008 Jun; 51(6):1552-6. PubMed ID: 18391094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On-treatment diastolic blood pressure and prognosis in systolic hypertension.
    Fagard RH; Staessen JA; Thijs L; Celis H; Bulpitt CJ; de Leeuw PW; Leonetti G; Tuomilehto J; Yodfat Y
    Arch Intern Med; 2007 Sep; 167(17):1884-91. PubMed ID: 17893310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving care coordination between nephrology and primary care: a quality improvement initiative using the renal physicians association toolkit.
    Haley WE; Beckrich AL; Sayre J; McNeil R; Fumo P; Rao VM; Lerma EV
    Am J Kidney Dis; 2015 Jan; 65(1):67-79. PubMed ID: 25183380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of lower achieved blood pressure on outcomes in hypertensive patients.
    Okin PM; Hille DA; Kjeldsen SE; Dahlöf B; Devereux RB
    J Hypertens; 2012 Apr; 30(4):802-10; discussion 810. PubMed ID: 22343536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Management of hypertension for prevention from cardiovascular events].
    Ueshima K
    Nihon Rinsho; 2011 Nov; 69(11):1993-8. PubMed ID: 22111320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Office management of hypertension in older persons.
    Aronow WS
    Am J Med; 2011 Jun; 124(6):498-500. PubMed ID: 21605724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension: Rest before blood pressure measurement: a lesson from SPRINT.
    Agarwal R
    Nat Rev Nephrol; 2016 Mar; 12(3):127-8. PubMed ID: 26804018
    [No Abstract]   [Full Text] [Related]  

  • 37. Redefining Blood-Pressure Targets--SPRINT Starts the Marathon.
    Perkovic V; Rodgers A
    N Engl J Med; 2015 Nov; 373(22):2175-8. PubMed ID: 26551394
    [No Abstract]   [Full Text] [Related]  

  • 38. Response by Bress et al to Letters Regarding Article, "Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections from NHANES (National Health and Nutrition Examination Survey)".
    Bress AP; Kramer H; Cooper RS
    Circulation; 2017 Sep; 136(12):1174-1175. PubMed ID: 28923909
    [No Abstract]   [Full Text] [Related]  

  • 39. How Does SPRINT (Systolic Blood Pressure Intervention Trial) Direct Hypertension Treatment Targets for CKD?
    Taler SJ
    Am J Kidney Dis; 2016 Jul; 68(1):15-8. PubMed ID: 27012910
    [No Abstract]   [Full Text] [Related]  

  • 40. Harm-benefit analysis: treatment of mild hypertension in low-risk individuals.
    Kean T
    Evid Based Nurs; 2019 Oct; 22(4):110. PubMed ID: 30948433
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.